BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34278491)

  • 1. Overview of serpin B9 and its roles in cancer (Review).
    Wang WJ; Wang J; Ouyang C; Chen C; Xu XF; Ye XQ
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serpin B9 controls tumor cell killing by CAR T cells.
    Kimman T; Slomp A; Martens A; Grabherr S; Li S; van Diest E; Meeldijk J; Kuball J; Minnema MC; Eldering E; Bovenschen N; Sebestyén Z; Peperzak V
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36931661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of human granzyme B variants resistant to serpin B9.
    Losasso V; Schiffer S; Barth S; Carloni P
    Proteins; 2012 Nov; 80(11):2514-22. PubMed ID: 22733450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Serpin B9 as a Prognostic Factor of Colorectal Cancer.
    Vycital O; Pitule P; Hosek P; Kriz T; Treska V; Liska V
    Anticancer Res; 2019 Nov; 39(11):6063-6066. PubMed ID: 31704833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serpins prevent granzyme-induced death in a species-specific manner.
    Bots M; VAN Bostelen L; Rademaker MT; Offringa R; Medema JP
    Immunol Cell Biol; 2006 Feb; 84(1):79-86. PubMed ID: 16405655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency.
    Hirst CE; Buzza MS; Bird CH; Warren HS; Cameron PU; Zhang M; Ashton-Rickardt PG; Bird PI
    J Immunol; 2003 Jan; 170(2):805-15. PubMed ID: 12517944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and characterization of a novel human Granzyme B inhibitor.
    Marcet-Palacios M; Ewen C; Pittman E; Duggan B; Carmine-Simmen K; Fahlman RP; Bleackley RC
    Protein Eng Des Sel; 2015 Jan; 28(1):9-17. PubMed ID: 25492933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serpins for diagnosis and therapy in cancer.
    Zheng D; Chen H; Davids J; Bryant M; Lucas A
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):123-32. PubMed ID: 23988000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of serine protease inhibitor isoform 3, SmSPI, from Schistosoma mansoni.
    Pakchotanon P; Molee P; Nuamtanong S; Limpanont Y; Chusongsang P; Limsomboon J; Chusongsang Y; Maneewatchararangsri S; Chaisri U; Adisakwattana P
    Parasitol Res; 2016 Aug; 115(8):2981-94. PubMed ID: 27083187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of the serpin superfamily.
    Law RH; Zhang Q; McGowan S; Buckle AM; Silverman GA; Wong W; Rosado CJ; Langendorf CG; Pike RN; Bird PI; Whisstock JC
    Genome Biol; 2006; 7(5):216. PubMed ID: 16737556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serpins, immunity and autoimmunity: old molecules, new functions.
    Gatto M; Iaccarino L; Ghirardello A; Bassi N; Pontisso P; Punzi L; Shoenfeld Y; Doria A
    Clin Rev Allergy Immunol; 2013 Oct; 45(2):267-80. PubMed ID: 23325331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of granzymes by serpins.
    Kaiserman D; Bird PI
    Cell Death Differ; 2010 Apr; 17(4):586-95. PubMed ID: 19893573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of serpins in vertebrate immunity.
    Mangan MS; Kaiserman D; Bird PI
    Tissue Antigens; 2008 Jul; 72(1):1-10. PubMed ID: 18498291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The granzyme B inhibitor, PI-9, is differentially expressed during placental development and up-regulated in hydatidiform moles.
    Buzza MS; Hosking P; Bird PI
    Placenta; 2006 Jan; 27(1):62-9. PubMed ID: 16310039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased proteinase inhibitor-9 (PI-9) and reduced granzyme B in lung cancer: mechanism for immune evasion?
    Soriano C; Mukaro V; Hodge G; Ahern J; Holmes M; Jersmann H; Moffat D; Meredith D; Jurisevic C; Reynolds PN; Hodge S
    Lung Cancer; 2012 Jul; 77(1):38-45. PubMed ID: 22387007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes.
    Sun J; Bird CH; Sutton V; McDonald L; Coughlin PB; De Jong TA; Trapani JA; Bird PI
    J Biol Chem; 1996 Nov; 271(44):27802-9. PubMed ID: 8910377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites.
    Bladergroen BA; Strik MC; Bovenschen N; van Berkum O; Scheffer GL; Meijer CJ; Hack CE; Kummer JA
    J Immunol; 2001 Mar; 166(5):3218-25. PubMed ID: 11207275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serpins, the vasculature, and viral therapeutics.
    Richardson J; Viswanathan K; Lucas A
    Front Biosci; 2006 Jan; 11():1042-56. PubMed ID: 16146796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serpins and regulation of cell death.
    Bird PI
    Results Probl Cell Differ; 1998; 24():63-89. PubMed ID: 9949832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SRP-2 is a cross-class inhibitor that participates in postembryonic development of the nematode Caenorhabditis elegans: initial characterization of the clade L serpins.
    Pak SC; Kumar V; Tsu C; Luke CJ; Askew YS; Askew DJ; Mills DR; Brömme D; Silverman GA
    J Biol Chem; 2004 Apr; 279(15):15448-59. PubMed ID: 14739286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.